Approval · Notice of Compliance 30778 · 2023
AURIMIC: Notice of Compliance 30778
Issued May 18, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30778
- Date
- May 18, 2023
- Company
- Vetviva Richter GmbhWels, --, Austria
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Change in product ownership
- Canadian reference product
- SUROLAN (Elanco, Division Of Eli Lilly Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AURIMIC | 02509725 | Marketed |
Medicinal ingredients
- MICONAZOLE NITRATE 23 MG per ML
- PREDNISOLONE ACETATE 5 MG per ML
- POLYMYXIN B SULFATE 0.5293 MG per ML